vs
Side-by-side financial comparison of AbbVie (ABBV) and US Foods Holding Corp. (USFD). Click either name above to swap in a different company.
AbbVie is the larger business by last-quarter revenue ($15.0B vs $9.8B, roughly 1.5× US Foods Holding Corp.). AbbVie runs the higher net margin — 4.6% vs 1.9%, a 2.8% gap on every dollar of revenue. On growth, AbbVie posted the faster year-over-year revenue change (9.9% vs 3.3%). Over the past eight quarters, US Foods Holding Corp.'s revenue compounded faster (4.6% CAGR vs 1.8%).
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
US Foods Holding Corp. is an American food service distributor. It is the second-largest food service distributor in the U.S., after Sysco. The company supplies 250,000 locations including independent restaurants, chain restaurants, healthcare, hospitality, and educational institutions.
ABBV vs USFD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $15.0B | $9.8B |
| Net Profit | $697.0M | $184.0M |
| Gross Margin | — | 17.6% |
| Operating Margin | 26.6% | 3.3% |
| Net Margin | 4.6% | 1.9% |
| Revenue YoY | 9.9% | 3.3% |
| Net Profit YoY | -46.0% | 178.8% |
| EPS (diluted) | $0.39 | $0.82 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $15.0B | — | ||
| Q4 25 | $16.6B | $9.8B | ||
| Q3 25 | $15.8B | $10.2B | ||
| Q2 25 | $15.4B | $10.1B | ||
| Q1 25 | $13.3B | $9.4B | ||
| Q4 24 | $15.1B | $9.5B | ||
| Q3 24 | $14.5B | $9.7B | ||
| Q2 24 | $14.5B | $9.7B |
| Q1 26 | $697.0M | — | ||
| Q4 25 | $1.8B | $184.0M | ||
| Q3 25 | $186.0M | $153.0M | ||
| Q2 25 | $938.0M | $224.0M | ||
| Q1 25 | $1.3B | $115.0M | ||
| Q4 24 | $-22.0M | $66.0M | ||
| Q3 24 | $1.6B | $148.0M | ||
| Q2 24 | $1.4B | $198.0M |
| Q1 26 | — | — | ||
| Q4 25 | 72.6% | 17.6% | ||
| Q3 25 | 66.4% | 17.2% | ||
| Q2 25 | 71.8% | 17.6% | ||
| Q1 25 | 70.0% | 17.3% | ||
| Q4 24 | 70.9% | 17.6% | ||
| Q3 24 | 70.9% | 17.1% | ||
| Q2 24 | 70.9% | 17.6% |
| Q1 26 | 26.6% | — | ||
| Q4 25 | 27.3% | 3.3% | ||
| Q3 25 | 12.1% | 2.8% | ||
| Q2 25 | 31.7% | 3.7% | ||
| Q1 25 | 28.0% | 2.4% | ||
| Q4 24 | -9.9% | 3.2% | ||
| Q3 24 | 26.5% | 2.9% | ||
| Q2 24 | 27.6% | 3.6% |
| Q1 26 | 4.6% | — | ||
| Q4 25 | 10.9% | 1.9% | ||
| Q3 25 | 1.2% | 1.5% | ||
| Q2 25 | 6.1% | 2.2% | ||
| Q1 25 | 9.6% | 1.2% | ||
| Q4 24 | -0.1% | 0.7% | ||
| Q3 24 | 10.8% | 1.5% | ||
| Q2 24 | 9.5% | 2.0% |
| Q1 26 | $0.39 | — | ||
| Q4 25 | $1.02 | $0.82 | ||
| Q3 25 | $0.10 | $0.67 | ||
| Q2 25 | $0.52 | $0.96 | ||
| Q1 25 | $0.72 | $0.49 | ||
| Q4 24 | $-0.03 | $0.28 | ||
| Q3 24 | $0.88 | $0.61 | ||
| Q2 24 | $0.77 | $0.80 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $41.0M |
| Total DebtLower is stronger | — | $5.1B |
| Stockholders' EquityBook value | — | $4.3B |
| Total Assets | — | $13.9B |
| Debt / EquityLower = less leverage | — | 1.18× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $5.3B | $41.0M | ||
| Q3 25 | $5.7B | $56.0M | ||
| Q2 25 | $6.5B | $61.0M | ||
| Q1 25 | $5.2B | $101.0M | ||
| Q4 24 | $5.6B | $59.0M | ||
| Q3 24 | $7.3B | $81.0M | ||
| Q2 24 | $13.2B | $405.0M |
| Q1 26 | — | — | ||
| Q4 25 | $58.9B | $5.1B | ||
| Q3 25 | $63.0B | $4.8B | ||
| Q2 25 | $63.0B | $4.7B | ||
| Q1 25 | $64.5B | $4.7B | ||
| Q4 24 | $60.3B | $4.8B | ||
| Q3 24 | $58.5B | $4.7B | ||
| Q2 24 | $58.0B | $4.6B |
| Q1 26 | — | — | ||
| Q4 25 | $-3.3B | $4.3B | ||
| Q3 25 | $-2.6B | $4.5B | ||
| Q2 25 | $-183.0M | $4.6B | ||
| Q1 25 | $1.4B | $4.6B | ||
| Q4 24 | $3.3B | $4.5B | ||
| Q3 24 | $6.0B | $4.6B | ||
| Q2 24 | $6.8B | $5.0B |
| Q1 26 | — | — | ||
| Q4 25 | $134.0B | $13.9B | ||
| Q3 25 | $133.9B | $14.0B | ||
| Q2 25 | $137.2B | $13.8B | ||
| Q1 25 | $136.2B | $13.7B | ||
| Q4 24 | $135.2B | $13.4B | ||
| Q3 24 | $143.4B | $13.5B | ||
| Q2 24 | $141.9B | $13.7B |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.18× | ||
| Q3 25 | — | 1.08× | ||
| Q2 25 | — | 1.02× | ||
| Q1 25 | 45.44× | 1.02× | ||
| Q4 24 | 18.15× | 1.06× | ||
| Q3 24 | 9.70× | 1.01× | ||
| Q2 24 | 8.56× | 0.92× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $293.0M |
| Free Cash FlowOCF − Capex | — | $159.0M |
| FCF MarginFCF / Revenue | — | 1.6% |
| Capex IntensityCapex / Revenue | — | 1.4% |
| Cash ConversionOCF / Net Profit | — | 1.59× |
| TTM Free Cash FlowTrailing 4 quarters | — | $959.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $5.2B | $293.0M | ||
| Q3 25 | $7.0B | $351.0M | ||
| Q2 25 | $5.2B | $334.0M | ||
| Q1 25 | $1.6B | $391.0M | ||
| Q4 24 | $7.0B | $283.0M | ||
| Q3 24 | $5.4B | $270.0M | ||
| Q2 24 | $2.3B | $482.0M |
| Q1 26 | — | — | ||
| Q4 25 | $4.9B | $159.0M | ||
| Q3 25 | $6.6B | $236.0M | ||
| Q2 25 | $4.9B | $257.0M | ||
| Q1 25 | $1.4B | $307.0M | ||
| Q4 24 | $6.8B | $178.0M | ||
| Q3 24 | $5.2B | $190.0M | ||
| Q2 24 | $2.0B | $413.0M |
| Q1 26 | — | — | ||
| Q4 25 | 29.4% | 1.6% | ||
| Q3 25 | 42.1% | 2.3% | ||
| Q2 25 | 31.7% | 2.5% | ||
| Q1 25 | 10.5% | 3.3% | ||
| Q4 24 | 44.7% | 1.9% | ||
| Q3 24 | 35.9% | 2.0% | ||
| Q2 24 | 14.0% | 4.3% |
| Q1 26 | — | — | ||
| Q4 25 | 2.0% | 1.4% | ||
| Q3 25 | 2.4% | 1.1% | ||
| Q2 25 | 1.7% | 0.8% | ||
| Q1 25 | 1.8% | 0.9% | ||
| Q4 24 | 1.9% | 1.1% | ||
| Q3 24 | 1.7% | 0.8% | ||
| Q2 24 | 1.7% | 0.7% |
| Q1 26 | — | — | ||
| Q4 25 | 2.87× | 1.59× | ||
| Q3 25 | 37.76× | 2.29× | ||
| Q2 25 | 5.49× | 1.49× | ||
| Q1 25 | 1.27× | 3.40× | ||
| Q4 24 | — | 4.29× | ||
| Q3 24 | 3.49× | 1.82× | ||
| Q2 24 | 1.66× | 2.43× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABBV
Segment breakdown not available.
USFD
| Product One | $3.5B | 36% |
| Product Two | $1.7B | 17% |
| Product Three | $1.7B | 17% |
| Product Four | $985.0M | 10% |
| Product Five | $901.0M | 9% |
| Product Six | $580.0M | 6% |
| Product Seven | $485.0M | 5% |
